News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Seongyeol Park: NCI JI 2024 fantastic scientific event
Photo from Seongyeol Park/X
Aug 27, 2024, 10:54

Seongyeol Park: NCI JI 2024 fantastic scientific event

Seongyeol Park, Post-doctoral researcher at Stanford Cancer Institute, shared on X:

“It was fantastic scientific event. I gained valuable insights into cancer research and connected with peers for discussions. Many thanks to NCI Division of Cancer Biology and the organizing committee.”

Source: Seongyeol Park/X

cancer Cancer research NCI NCI Division of Cancer Biology OncoDaily Oncology Seongyeol Park
Special Coverage
Insight
Aug 27, 2025, 22:45
Gagan Brar: Reviewing the Role of Immunotherapy in Colorectal Cancers and Other Solid Tumors
Voices
Aug 27, 2025, 21:37
Nina Niu Sanford Explores ctDNA in CRC with Kristen Ciombor
Positive
Aug 27, 2025, 20:54
Praveen Kumar Marimuthu: Discussing Financial Toxicity with Fumiko Ladd Chino
Voices
Aug 27, 2025, 20:43
John M. Salsman: Grateful to Contribute to the AYACSM and Elevate AYA Voices with ASCO
Blog Posts
Aug 27, 2025, 20:41
Harold Burstein: How Not To Give Grand Rounds
Voices
Aug 27, 2025, 20:29
ASCO Calls for Action: Preserving America's Legacy in Cancer Research
Voices
Aug 27, 2025, 20:22
E. Shyam P. Reddy: How Cancer Cells Hide from the Immune System
Voices
Aug 27, 2025, 20:17
Kash Sarabi: Reflecting on the Painful Journey of Cancer Treatment and the Need for Change in Approval Processes
Positive
Aug 27, 2025, 20:08
Welcoming the New Board Members to the Office - ASTRO
Positive
Aug 27, 2025, 20:01
Diane Bodurka: Welcoming a New Academic Year at MD Anderson
Blog Posts
Aug 27, 2025, 19:51
Fumiko Ladd Chino: What Makes Us Excited to Be in Radiation Oncology
Voices
Aug 27, 2025, 19:42
Ben Derman: Puzzling Together MRD Negativity and the ODAC Vote in Myeloma